Pfizer's (NYSE:PFE) stock up by 7.7% over the past three months. However, we decided to study the company's mixed-bag of ...

Key Points Pfizer and Novo Nordisk have underperformed the market over the past year.But both should remain major players in ...

Financial Performance and 2025 Guidance Pfizer’s financial performance has shown resilience in the face of market uncertainties, generating revenue of $62.46 billion in the last twelve months.

This comprehensive analysis delves into Pfizer’s current position, future prospects, and the factors that could shape its trajectory in the coming years. Financial Performance and Guidance Pfizer’s ...

Pfizer (NYSE:PFE) has had a rough month with its share price down 2.9%. It is possible that the markets have ignored the company's differing financials and decided to lean-in to the negative ...

We upgraded the rating for Pfizer (PFE) stock, citing positive trends within the company and in the market, despite recent drop after Q2 earnings. Learn more here.

Mohit Bansal’s rating is based on a nuanced analysis of Pfizer’s recent financial performance and future prospects. Despite Pfizer’s revenue exceeding expectations in the first quarter of ...

Pfizer Inc. (NYSE: PFE) reported financial results for fourth quarter and full-year 2023 and reaffirmed its 2024 financial guidance (5) provided on Dec ...

David Risinger has given his Hold rating due to a combination of factors influencing Pfizer’s financial projections and market performance expectations.

The pharma giant's future financial performance is a matter of debate. Pfizer (PFE -1.51%) is a stock that everyone's familiar with, but that doesn't mean that everyone agrees you should buy it.

One reason for Pfizer's weaker financial performance this year is due to shelter-in-place measures related to the COVID-19 pandemic that have slowed demand for new prescriptions and vaccinations.

Pfizer due to report earnings before the bell Tuesday. The pharma giant has consistently outpaced Wall Street’s expectations, beating them 14 of the last 15 quarters. Shares of PFE have lost ...